الولايات المتحدة · منصات وبيانات · MarketBeat
Cellebrite DI Ltd. (NASDAQ:CLBT) Stock Has Consensus Price Target of $14.75

ملخص مفصل
Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company
يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)



